Clinical Trial Update: A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) [Phase 2]

View source ↗

Summary

A Phase 2 study of DS-8201a in metastatic breast cancer previously treated with trastuzumab emtansine (T-DM1) was terminated. Results were posted in February 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DS-8201a (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-02-17